Elsevier and Kanazawa University in Japan Collaborate to Map University’s Research Performance
SciVal® brings insights that will help Kanazawa University collaborate with industry partners and acquire more research fundingTokyo, January31, 2013, - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced its collaboration with Kanazawa University in Japan by providing access to SciVal and consultative support in mapping the university’s research performance.
With the help of SciVal Consultants, Kanazawa University used SciVal to map out its research expertise and areas of growth, identify potential resources to accelerate funding acquisition and gather actionable insights to enhance collaboration between the university and industry partners. These analyses, which were conducted during the past months, will be used by Kanazawa University’s research administrators (URAs) as a basis for defining the university’s future research strategy.
“Using Elsevier’s SciVal suite we have been able to make a concrete industry-university matching list and benchmark local funding opportunities,” said Professor Koetsu Yamazaki, Vice President for Research and Director of Organization of Frontier Science and Innovation at Kanazawa University. “Based on these findings we have now outlined various interesting industry-university cooperation projects which we aim to incorporate into the university’s research strategy.”
Niels Weertman, Vice President of SciVal at Elsevier, added, “We are very happy to support Professor Yamazaki and other URAs at Kanazawa University in their research evaluation activities by not only providing access to SciVal, but also by supporting the team with our expertise in data interpretation. Through our collaborative approach, we will continually work with Kanazawa University to advance their research strategies, pinpoint emerging trends, and identify new opportunities for collaboration both locally and internationally.”
Kanazawa University is a national university in Japan with a 150-year history, originally established as a Hikoso Vaccination Center in 1862. The university has three colleges, sixteen schools and five graduate schools with 10,000 students mainly based in Kanazawa, Ishikawa prefecture. The university represents a higher education institute in Hokuriku region and aims to be a research and education university open to the region and to the world. For more information: http://www.kanazawa-u.ac.jp and http://www.experts.scival.com/kanazawa.
About Elsevier’s SciVal suite
Designed to support the many stages of the research planning cycle, Elsevier’s SciVal® suite of solutions provides information about research performance, funding and expertise to enable informed decision-making and drive successful outcomes. Serving research institutions, funding agencies and policy bodies, SciVal delivers objective analytical capabilities that can enhance the performance of individuals, teams and organizations. SciVal integrates institutional and external data sources with information from Elsevier’s Scopus®, the standard for bibliometric research tools, to offer trusted solutions including SciVal Experts, SciVal Funding, SciVal Spotlight, SciVal Strata, SciVal Analytics and Pure.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+81 3 5561 5069